NEOE:JNJ (USA)
Â
Canadian Depository Receipt (CAD Hedged)
C$
19.40
(-3.44%)
May 29
Current and historical daily PE Ratio for Johnson & Johnson (
) from 2023 to May 29 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Johnson & Johnson stock (NEOE:JNJ) PE ratio as of May 29 2024 is 9.51.
More Details
Johnson & Johnson (NEOE:JNJ) PE Ratio (TTM) Chart
Johnson & Johnson (NEOE:JNJ) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 177
- 1
- 2
| Johnson & Johnson PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-30 | 0.9 | 2024-03-26 | 1.1 |
| 2024-05-29 | 0.9 | 2024-03-25 | 1.1 |
| 2024-05-28 | 0.9 | 2024-03-22 | 1.1 |
| 2024-05-27 | 1.0 | 2024-03-21 | 1.1 |
| 2024-05-24 | 1.0 | 2024-03-20 | 1.1 |
| 2024-05-23 | 1.0 | 2024-03-19 | 1.1 |
| 2024-05-22 | 1.0 | 2024-03-18 | 1.1 |
| 2024-05-21 | 1.0 | 2024-03-15 | 1.1 |
| 2024-05-17 | 1.0 | 2024-03-14 | 1.1 |
| 2024-05-16 | 1.0 | 2024-03-13 | 1.2 |
| 2024-05-15 | 1.0 | 2024-03-12 | 1.2 |
| 2024-05-14 | 1.0 | 2024-03-11 | 1.2 |
| 2024-05-13 | 1.0 | 2024-03-08 | 1.1 |
| 2024-05-10 | 1.0 | 2024-03-07 | 1.1 |
| 2024-05-09 | 1.0 | 2024-03-06 | 1.1 |
| 2024-05-08 | 1.0 | 2024-03-05 | 1.2 |
| 2024-05-07 | 1.0 | 2024-03-04 | 1.1 |
| 2024-05-06 | 1.0 | 2024-03-01 | 1.2 |
| 2024-05-03 | 1.0 | 2024-02-29 | 1.2 |
| 2024-05-02 | 1.0 | 2024-02-28 | 1.2 |
| 2024-05-01 | 1.0 | 2024-02-27 | 1.2 |
| 2024-04-30 | 0.9 | 2024-02-26 | 1.2 |
| 2024-04-29 | 1.0 | 2024-02-23 | 1.2 |
| 2024-04-26 | 1.0 | 2024-02-22 | 1.2 |
| 2024-04-25 | 1.0 | 2024-02-21 | 1.1 |
| 2024-04-24 | 1.0 | 2024-02-20 | 1.1 |
| 2024-04-23 | 1.0 | 2024-02-19 | 1.1 |
| 2024-04-22 | 1.0 | 2024-02-16 | 1.1 |
| 2024-04-19 | 1.0 | 2024-02-15 | 1.1 |
| 2024-04-18 | 1.0 | 2024-02-14 | 1.1 |
| 2024-04-17 | 0.9 | 2024-02-13 | 1.1 |
| 2024-04-16 | 0.9 | 2024-02-12 | 1.1 |
| 2024-04-15 | 1.0 | 2024-02-09 | 1.1 |
| 2024-04-12 | 1.0 | 2024-02-08 | 1.1 |
| 2024-04-11 | 1.0 | 2024-02-07 | 1.1 |
| 2024-04-10 | 1.0 | 2024-02-06 | 1.1 |
| 2024-04-09 | 1.0 | 2024-02-05 | 1.1 |
| 2024-04-08 | 1.0 | 2024-02-02 | 1.1 |
| 2024-04-05 | 1.0 | 2024-02-01 | 1.1 |
| 2024-04-04 | 1.0 | 2024-01-31 | 1.1 |
| 2024-04-03 | 1.0 | 2024-01-30 | 1.1 |
| 2024-04-02 | 1.0 | 2024-01-29 | 1.1 |
| 2024-04-01 | 1.0 | 2024-01-26 | 1.1 |
| 2024-03-28 | 1.0 | 2024-01-25 | 1.1 |
| 2024-03-27 | 1.1 | 2024-01-24 | 1.1 |
Johnson & Johnson (NEOE:JNJ) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Johnson & Johnson
NAICS : 325412
SIC : 2834
ISIN : CA47817E1034
Share Class Description:
NEOE:JNJ: Canadian Depository Receipt (CAD Hedged)Compare
Compare
Traded in other countries / regions
JNJ.USA0R34.UKJNJ.ArgentinaJNJB34.BrazilJNJ.CanadaJNJ.GermanyJNJ.MexicoJNJ.ChileJNJ.Peru1JNJ.ItalyJNJ.AustriaJNJ.BulgariaJNJ_KZ.KazakhstanJNJ.Ukraine IPO Date
2023-09-19Description
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers